Article
Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.
Scientific reports - 24 Apr 2018
Christiansen D, Earnest-Silveira L, Chua B, Meuleman P, Boo I, Grubor-Bauk B, Jackson D C, Keck Z Y, Foung S K H, Drummer H E, Gowans E J, Torresi J
Abstract excerpt
The significant public health problem of Hepatitis C virus (HCV) has been partially addressed with the advent of directly acting antiviral agents (DAAs). However, the development of an effective preventative vaccine would have a significant impact on HCV incidence and would represent a major advance towards controlling and possibly eradicating HCV globally. We previously reported a genotype 1a HCV viral-like...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.